← Leaderboards
Charles H Cook
Ohio State University
$4,900,163
Attributed
$6,292,739
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $737.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,292,739 · 3
By mechanism
R01$6,292,739 · 3
Top collaborators
- Sean Edward Lawler6 shared
Most similar at Ohio State University
Same institution · by research overlap
- Ginny L Bumgardner$11,783,970
- Michael D Lairmore$5,085,750
- Kristine E Yoder$6,387,948
- Anne M Vanbuskirk$616,796
- Jasmine Ashley Tuazon$37,018
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusImmuneImmunocompetentClinical TrialsVirusCytomegalovirus InfectionsPreventNovel StrategiesMediatingImmunoglobulin GIn VivoResponseHerpesviridaeMolecularMouse ModelMalignant NeoplasmsAffectLinkAreaLungImmunotherapyGlioblastomaDiagnosisAntiviral Agents
Grant awards (19)
Defining the role of cytomegalovirus in glioblastoma therapies$653,127
R01 · FY2025 · CA
Defining the role of cytomegalovirus in glioblastoma therapies$620,471
R01 · FY2024 · CA
Defining the role of cytomegalovirus in glioblastoma therapies$84,875
R01 · FY2024 · CA
Defining the role of cytomegalovirus in glioblastoma therapies$648,427
R01 · FY2023 · CA
Defining the role of cytomegalovirus in glioblastoma therapies$89,342
R01 · FY2023 · CA
Defining the role of cytomegalovirus in glioblastoma therapies$688,910
R01 · FY2022 · CA
Bacterial Sepsis and Reactivation of Latent Cytomegalovirus$331,670
R01 · FY2014 · GM · contact PI
Bacterial Sepsis and Reactivation of Latent Cytomegalovirus$171,410
R01 · FY2013 · GM · contact PI
Bacterial Sepsis and Reactivation of Latent Cytomegalovirus$99,572
R01 · FY2013 · GM · contact PI
Bacterial Sepsis and Reactivation of Latent Cytomegalovirus$301,950
R01 · FY2012 · GM · contact PI
Bacterial Sepsis and Reactivation of Latent Cytomegalovirus$301,950
R01 · FY2011 · GM · contact PI
THE IMMUNOBIOLOGY OF MURINE ALLOGRAFT ACCEPTANCE$279,713
R01 · FY2007 · AI · contact PI
Bacterial Sepsis & Reactivation of Latent Cytomegalovirus$276,917
R01 · FY2007 · GM · contact PI
THE IMMUNOBIOLOGY OF MURINE ALLOGRAFT ACCEPTANCE$288,068
R01 · FY2006 · AI · contact PI
Bacterial Sepsis & Reactivation of Laten Cytomegalovirus$285,187
R01 · FY2006 · GM · contact PI
THE IMMUNOBIOLOGY OF MURINE ALLOGRAFT ACCEPTANCE$295,000
R01 · FY2005 · AI
Bacterial Sepsis &Reactivation of Laten Cytomegalovirus$292,050
R01 · FY2005 · GM
Bacterial Sepsis &Reactivation of Laten Cytomegalovirus$292,050
R01 · FY2004 · GM
Bacterial Sepsis &Reactivation of Latent Cytomegaloviru$292,050
R01 · FY2003 · GM